Abstract
When a primary care clinician identifies a patient with an alcohol use disorder, there is a high likelihood that this patient has a psychiatric comorbidity. In the National Epidemiologic Survey on Alcoholism and Related Conditions (NESARC), a study representative of the US population, 40.7 % of people who sought treatment for alcohol dependence had at least one mood disorder and 33 % had at least one anxiety disorder [Grant BF, Stinson FS, Dawson DA, et al. Prevalence and Co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry. 2004;61:807–816.]. People who are at-risk drinkers, though they do not meet criteria for dependence or abuse, have higher rates of psychiatric comorbidity than lower risk drinkers or those who abstain from alcohol [Bott K, Meyer C, Rumpf HJ, et al. Psychiatric disorders among at-risk consumers of alcohol in the general population. J Stud Alcgohol. 2005,66: 246–253]. If left untreated, mood, anxiety and other psychiatric disorders can interfere with successful treatment and recovery from alcohol dependence, increase the chance of relapse and lead to overall poorer health outcomes. In the worst-case scenario, these conditions can be fatal, as alcohol use is a significant risk factor for suicide. When treating a patient with an alcohol-related illness, it is important to detect and treat comorbid psychiatric illnesses. It is also important to be able to do an appropriate safety assessment so that a patient can be referred to a higher level of psychiatric care (e.g., psychiatrist, hospital), when necessary.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grant BF, Stinson FS, Dawson DA, et al. Prevalence and Co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry. 2004;61:807–816.
Bott K, Meyer C, Rumpf HJ, et al. Psychiatric disorders among at-risk consumers of alcohol in the general population. J Stud Alcgohol. 2005, 66:246–253.
Reiger DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse:results for the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264: 2511–2518.
Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62:1097–1106.
Tamkin AS, Carson MF, Nixon DH, Hyer LA. A comparison among some measures of depression in male alcoholics. J Stud Alcohol. 1987;48(2):176–178.
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.
Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA. 2004;291(15):1887–1896.
Salloum IM, Cornelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2005;62:37–45.
Rubio G, Lopez-Munoz F, Alamo C. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disorder. 2006;8:289–293.
Brown RI, Wolfe J. Substance abuse and post-traumatic stress disorder co-morbidity. Drug Alcohol Depend. 1994;35:51–59
Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004;161:1426–1432.
Najavits LM, Weiss RD, Shaw SR, Muenz LR. Seeking Safety: outcome of a new cognitive-behavioral psychotherapy for women with post-traumatic stress disorder and substance dependence. J Traumatic Stress. 1998;11(3):437–456.
Beck AT, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consulting Clinical Psychology. 1998;56(6):893–897.
Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Int Med. 2006;166(10):1092–1097.
Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Prim Care Psychiatry. 2003;9:9–14.
Barbee JG, Clark, PD, Crapanzano BS, et al. Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. Nervous Mental Dis. 1989;177(7):379–441.
Brunette MF, Drake RE, Xie H, et al. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull. 2006;32:637–643.
Beresford TP, Clapp L, Martin B, et al. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol. 2005;25:363–366.
Center for Substance Abuse Treatment. Substance abuse treatment for persons with co-occurring disorders. TIP series 42. HHS Publication No. (SMA) 08-3992. Rockville: SAMHSA; 2005.
Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111:179–185.
Bernal M, Haron JM, Bernet S, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disorders. 2007;101:27–34.
Flensbirg-Madsen T, Knop J, Mortensen EL, et al. Alcohol use disorders increase the risk of completed suicide-irrespective of other psychiatric disorders. A longitudinal cohort study. Psych Res. 2009;167:123–130.
Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism, and schizophrenia. Br J Psychiatry. 1998;172:35–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harrington, A. (2013). Psychiatric Comorbidity. In: Saitz, R. (eds) Addressing Unhealthy Alcohol Use in Primary Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4779-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4779-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4778-8
Online ISBN: 978-1-4614-4779-5
eBook Packages: MedicineMedicine (R0)